Acorah Software Products - Accounts Production 19.2.450 false true 30 September 2024 1 October 2023 false 1 October 2024 30 September 2025 30 September 2025 14376903 Dr D E Miller Dr O Mateszko iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14376903 2024-09-30 14376903 2025-09-30 14376903 2024-10-01 2025-09-30 14376903 frs-core:CurrentFinancialInstruments 2025-09-30 14376903 frs-core:ComputerEquipment 2025-09-30 14376903 frs-core:ComputerEquipment 2024-10-01 2025-09-30 14376903 frs-core:ComputerEquipment 2024-09-30 14376903 frs-core:ShareCapital 2025-09-30 14376903 frs-core:RetainedEarningsAccumulatedLosses 2025-09-30 14376903 frs-bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 14376903 frs-bus:FilletedAccounts 2024-10-01 2025-09-30 14376903 frs-bus:SmallEntities 2024-10-01 2025-09-30 14376903 frs-bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 14376903 frs-bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 14376903 frs-core:DeferredTaxation 2024-10-01 2025-09-30 14376903 frs-core:DeferredTaxation 2024-09-30 14376903 frs-core:DeferredTaxation 2025-09-30 14376903 frs-bus:Director1 2024-10-01 2025-09-30 14376903 frs-bus:Director2 2024-10-01 2025-09-30 14376903 frs-countries:EnglandWales 2024-10-01 2025-09-30 14376903 2023-09-30 14376903 2024-09-30 14376903 2023-10-01 2024-09-30 14376903 frs-core:CurrentFinancialInstruments 2024-09-30 14376903 frs-core:ShareCapital 2024-09-30 14376903 frs-core:RetainedEarningsAccumulatedLosses 2024-09-30
Registered number: 14376903
Moorside Anaesthesia Ltd
Unaudited Financial Statements
For The Year Ended 30 September 2025
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 14376903
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 469 781
469 781
CURRENT ASSETS
Debtors 5 6,000 6,750
Cash at bank and in hand 44,327 22,495
50,327 29,245
Creditors: Amounts Falling Due Within One Year 6 (13,799 ) (8,928 )
NET CURRENT ASSETS (LIABILITIES) 36,528 20,317
TOTAL ASSETS LESS CURRENT LIABILITIES 36,997 21,098
PROVISIONS FOR LIABILITIES
Deferred Taxation 7 (89 ) (148 )
NET ASSETS 36,908 20,950
CAPITAL AND RESERVES
Called up share capital 9 200 200
Profit and Loss Account 36,708 20,750
SHAREHOLDERS' FUNDS 36,908 20,950
Page 1
Page 2
For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr D E Miller
Director
11/06/2026
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Moorside Anaesthesia Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14376903 . The registered office is 18 Moorside, Sheffield, S10 4LN.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment 25% straight line
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: NIL)
- -
4. Tangible Assets
Computer Equipment
£
Cost
As at 1 October 2024 1,249
As at 30 September 2025 1,249
Depreciation
As at 1 October 2024 468
Provided during the period 312
As at 30 September 2025 780
Net Book Value
As at 30 September 2025 469
As at 1 October 2024 781
Page 3
Page 4
5. Debtors
2025 2024
£ £
Due within one year
Trade debtors 6,000 6,750
6. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Corporation tax 4,037 2,090
Accruals and deferred income 904 885
Directors' loan accounts 8,858 5,953
13,799 8,928
7. Deferred Taxation
The provision for deferred tax is made up as follows:
2025 2024
£ £
Other timing differences 89 148
8. Provisions for Liabilities
Deferred Tax Total
£ £
As at 1 October 2024 148 148
Deferred taxation (59 ) (59 )
Balance at 30 September 2025 89 89
9. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 200 200
Page 4